Financials

  • Market Capitalization 5.55 M
  • Employee 3
  • Founded 2010
  • CEO N/A
  • Website www.silopharma.com
  • Headquarter Nevada, United States
  • FIGI BBG002D1DZ06
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.06
Price to sales ratio
43.51

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4938
LIMN
Liminatus Pharma, Inc. - Class A Common Stock
0.12 USD+20.00%0.00%0.00%-97.86%5.39 M USD
4939
ADIL
Adial Pharmaceuticals, Inc - Common Stock
2.69 USD+1.51%-7.24%-3.93%+607.89%5.77 M USD
4952
SNGX
Soligenix, Inc. - Common Stock
0.38 USD+2.70%0.00%-13.64%-66.37%5.63 M USD
4955
NCNA
NuCana plc - American Depositary Shares
1.32 USD+0.76%-1.49%-32.65%-38.60%5.49 M USD

Frequently asked questions about Silo Pharma Inc -, effectuated 1:50 R/S on 9/15

What is the Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock price today?

The current price of Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 (SILO) is 5.12. Over the past 24 hours, the stock has changed by -0.19%. Follow the SILO chart for real-time price dynamics.

What is the stock ticker of Silo Pharma Inc -, effectuated 1:50 R/S on 9/15?

Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 trades under the ticker SILO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock going up?

SILO has changed by -21.23% over the last week, -20.12% over the last month, and +782.76% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 net income for the last quarter?

Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 reported net income of -1.65 M for the last quarter. The previous quarter showed -881.53 K, which means net income changed by -86.85%.

How many employees does Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 have?

As of the latest available data, Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 has 3 employees. Workforce size can provide additional context about the company's scale and operations.

What is Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 EBITDA?

Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 EBITDA is -1.59 M, and its EBITDA margin is -8 830.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock?

You can buy Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 (SILO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock?

Investing in Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SILO chart and related analysis on metatrader.com as part of your research.

News